Miebo Drop Update and Buying It For Less
I’ll apologize in advance for this, but the more I dug into this issue, the angrier I became.
Last week, I shared my struggle with dry eyes and the absurdly high price of the Miebo Eye Drops I was prescribed by my physician. Many of you shared your own struggles with DED(dry eye disease), and what you’re using. Several readers came to my rescue and let me know that the exact same formula has been sold over the counter for years at a fraction of the cost…so I began researching it.
In a 2023 news release, Bausch + Lomb Corp announced the commercial launch of their single ingredient, perfluorohexyloctane ophthalmic solution, as the first and only prescription eye drop approved for DED that directly targets tear evaporation. That statement is true at face value but rather misleading.
According to Ophthalmology Times Europe, Miebo is a brand name for perfluorohexyloctane, which is also sold under the brand names EvoTears and Novatears in other countries. Novatears have been available without a prescription in Australia and New Zealand since 2013. EvoTears has been available over the counter in Europe since 2015.
Without insurance, Miebo is in the $925.00 range for 3ml in the USA, which is a one-month supply. With my co-pay, it’ll cost me $411.00. There are several places to buy the Meibo Eye Drop formula for less. I ordered several bottles of EvoTears from here, and I also found them here for under $20 each.
I’m annoyed that it’s taken the FDA over 12 years to approve this medication. With over 38 million Americans struggling with dry eyes, it should not have taken them this long to approve it. And why are they allowing Bauch+Lomb to charge us and our health insurance companies such an exorbitant price?
I’m not a doctor and I’m not suggesting you use them, but I’m delighted to be able to try them at an affordable price, so thank you for sharing with me.
Source link
Leave a Reply